pith. machine review for the scientific record. sign in

arxiv: 2604.23191 · v1 · submitted 2026-04-25 · ⚛️ physics.chem-ph

Recognition: unknown

Effects of Porous Media Properties and Flow Environment on Drug Release from Porous Implants

Pawan Kumar Pandey , KVS Chaithanya , Prateek K. Jha
Authors on Pith no claims yet

Pith reviewed 2026-05-08 07:15 UTC · model grok-4.3

classification ⚛️ physics.chem-ph
keywords porous implantsdrug releaseForchheimer-Darcy flowtime-dependent rate constantReynolds numberspecies transportnumerical simulation
0
0 comments X

The pith

Drug release from porous implants accelerates in later stages at high Reynolds numbers while extending operational time.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

This paper uses numerical simulations to examine how fluid flow conditions and porous media properties control drug release from Drug-Filled Porous Implants. Flow through the implant is modeled with the Forchheimer-extended Darcy law and drug movement is tracked with a diluted species transport equation. Release profiles are then fitted to an apparent first-order process whose rate constant changes with time. The simulations show that this rate constant increases during the final stages of release especially at high Reynolds numbers, while the implant continues to function over a longer period. These patterns indicate how flow environment can shape delivery behavior in porous drug systems.

Core claim

Drug release from DFPIs is represented as an apparent first-order process with a time-dependent rate constant. Simulations reveal that this rate constant rises in the later stages of release under high Reynolds number flow conditions, while the overall configuration preserves a prolonged operational time for the implant. The model combines Forchheimer-extended Darcy flow inside the homogeneous saturated porous medium with species transport both within the implant and into the surrounding channel.

What carries the argument

The time-dependent rate constant fitted to an apparent first-order release model, which quantifies how changes in Reynolds number and porous properties modify the drug release profile over time.

If this is right

  • High Reynolds number flows produce an increase in the effective release rate constant during late stages.
  • The implant maintains extended operational periods under the flow conditions that trigger the late-stage rate increase.
  • Drug availability in the surrounding channel varies with both porous media characteristics and external flow environment.
  • The observed kinetics support development of DFPI designs that adapt delivery to specific application needs.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The time-dependent rate approach could be tested on other porous drug carriers such as scaffolds or beads under dynamic flow.
  • Varying implant porosity or permeability might amplify or dampen the late-stage rate increase predicted by the model.
  • In vivo flow conditions with pulsatile rather than steady flow could alter the timing of the observed rate constant changes.

Load-bearing premise

The complex release process can be accurately captured by modeling it as an apparent first-order process with a time-dependent rate constant.

What would settle it

Laboratory measurements of cumulative drug release versus time from a DFPI in a flow channel at high Reynolds number, which would confirm or refute whether the effective rate constant increases after an initial period.

Figures

Figures reproduced from arXiv: 2604.23191 by KVS Chaithanya, Pawan Kumar Pandey, Prateek K. Jha.

Figure 1
Figure 1. Figure 1: Schematic of a channel containing a drug view at source ↗
Figure 3
Figure 3. Figure 3: ) increases with a decrease in either the permeability or the Reynolds number. Notably, the effect of permeability is more pronounced compared to the Reynolds number in determining the outflow span view at source ↗
Figure 2
Figure 2. Figure 2: Flow structures around the DFPI for (a) Re = 1 and (b) Re = 100. Flow structures are visualized using streamlines for porous medium properties: K = 10−12 m2 , ϵ = 0.1, Deff = Dclear ∙ ϵ 4/3 . For low permeability cases (K = 10−12 m2 ), the flow patterns exhibit divergence at the downstream face for Reynolds numbers of 100 and 10, as shown in view at source ↗
Figure 4
Figure 4. Figure 4: x-component of velocity vs. x, along the horizontal centreline passing through channel, in (a) the channel, and (b) zoomed-in view inside the DFPI. Results are compared for different Reynolds number (Re) for porous medium properties: K = 10−12 m2 , ϵ = 0.1, Deff = Dclear ∙ ϵ 4/3 m2 /𝑠. B. Drug Release Behavior view at source ↗
Figure 6
Figure 6. Figure 6: Average drug concentration (normalized) outside the DFPI with time for (a) different Reynolds number (Re) with K = 10−12 m2 , ϵ = 0.1, Deff = Dclear ∙ ϵ 4/3 ; (b) different porosity (ϵ) with K = 10−12 m2 , Re = 1, Deff = Dclear ∙ ϵ 4/3 ; (c) different Permeability (K) with Re = 0.01,100, ϵ = 0.1, Deff = Dclear ∙ ϵ 4/3 . The influence of flow structures, as discussed in view at source ↗
Figure 7
Figure 7. Figure 7: Drug concentration in DFPI at time instants when drug is 75%, 50%, and 25% remaining in DFPI. Results are shown for (a) K = 10−12 m2 , ϵ = 0.1, Deff = Dclear ∙ ϵ 4/3 and (b) K = 10−9 m2 , ϵ = 0.1, Deff = Dclear ∙ ϵ 4/3 view at source ↗
Figure 8
Figure 8. Figure 8: shows the drug concentration distribution in the entire channel (including DFPI) at the time instant when the 75% of initially loaded drug is remaining in the DFPI. Since the results are shown based on the same amount of drug remaining in the implant – contour for different cases correspond to different time instants. Interestingly, higher concentration levels are observed outside the DFPI at higher Reynol… view at source ↗
Figure 9
Figure 9. Figure 9: Variation of first order rate constant with view at source ↗
Figure 10
Figure 10. Figure 10: Variation of (a) rate constant (k) with time; (b) total flux with time for different Reynolds number (Re) with DFPI properties: K = 10−12 m2 , ϵ = 0.1, Deff = 10−13 m2 /𝑠; and (c) total flux with time for different Reynolds number (Re) with DFPI properties: K = 10−12 m2 , ϵ = 0.1, Deff = Dclear ∙ ϵ 4 3 view at source ↗
read the original abstract

Drug-Filled Porous Implants (DFPIs) are an innovative solution for delivering drugs in a controlled and sustained manner to target sites. To optimize their performance across various physiological conditions, it is essential to understand how fluid flow and porous media properties influence the drug release process. In this work, we numerically investigate a wide range of flow conditions and their effects on drug release from DFPI. The DFPI is modeled as a homogeneous, saturated porous medium, with flow through the porous structure modeled using the Forchheimer-extended Darcy law. Drug diffusion within the DFPI and its transport through the surrounding channel are simulated using a diluted species transport approach. The results reveal the impact of flow conditions and porous media characteristics on the drug release profile of the implant and drug availability within the channel. The variations in drug release behavior are analyzed by modeling the release as an apparent first-order process with a time-dependent rate constant. Notably, the results highlight specific conditions under which the rate constant increases during the later stages of drug release from the DFPI, particularly at high Reynolds numbers, while also ensuring a prolonged operational time period of the implant. These findings suggest the potential for developing intelligent DFPI designs capable of delivering drugs in a manner more attuned to the specific needs of the application.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

3 major / 2 minor

Summary. The paper numerically investigates drug release from drug-filled porous implants (DFPIs) modeled as homogeneous saturated porous media. Flow is governed by the Forchheimer-extended Darcy law, and drug transport is modeled via diluted-species advection-diffusion equations in the implant and surrounding channel. Release profiles are post-processed by fitting the integrated drug mass M(t) to an apparent first-order form with time-dependent rate constant k(t). The central claim is that k(t) increases during later stages of release, particularly at high Reynolds numbers, while supporting prolonged implant operation, with implications for intelligent DFPI design.

Significance. If the reported non-monotonic k(t) behavior is shown to be robust rather than a fitting artifact, the work could provide useful numerical guidance for tailoring porous implant performance to physiological flow conditions. The modeling framework (Forchheimer-Darcy plus species transport) is standard and appropriate for the problem, and the broad parameter exploration of Re and porous properties is a strength. However, without experimental validation or quantitative fit diagnostics, the translational significance remains limited to preliminary modeling insights.

major comments (3)
  1. [§4] §4 (drug release kinetics analysis): The post-processing of M(t) via dM/dt = -k(t)M is presented without derivation from the underlying advection-diffusion equations or any justification for why a first-order form should hold once advection dominates at high Re. The claimed late-stage increase in k(t) lacks support from R² values, residual plots, or comparisons to alternative models (e.g., Higuchi or direct PDE solution), raising the possibility that the trend is an artifact of forcing an exponential fit onto convectively flushed profiles.
  2. [§3] §3 (numerical methods): No mesh convergence studies, solver tolerances, or specific ranges/values for permeability, porosity, and the Forchheimer coefficient are reported. These choices are load-bearing for the reliability of the simulated release curves and the extracted k(t) trends.
  3. [Abstract and §5] Abstract and §5 (conclusions): The statement that the conditions 'ensure a prolonged operational time period' is not quantified (e.g., via time-to-50%-release or comparison metrics across Re), weakening the link between the k(t) observation and the design implication.
minor comments (2)
  1. [§3] Notation for the time-dependent rate constant k(t) should be introduced with an explicit equation in the methods or results to avoid ambiguity in how it is computed from M(t).
  2. [Figures] Figure captions for release profiles and k(t) curves would benefit from explicit mention of the Reynolds number range and porous property values used in each panel for easier cross-reference with the text.

Simulated Author's Rebuttal

3 responses · 0 unresolved

We thank the referee for their constructive and detailed review of our manuscript. We have addressed each major comment point by point below and will incorporate revisions to improve the rigor and clarity of the work.

read point-by-point responses

  1. Referee: [§4] §4 (drug release kinetics analysis): The post-processing of M(t) via dM/dt = -k(t)M is presented without derivation from the underlying advection-diffusion equations or any justification for why a first-order form should hold once advection dominates at high Re. The claimed late-stage increase in k(t) lacks support from R² values, residual plots, or comparisons to alternative models (e.g., Higuchi or direct PDE solution), raising the possibility that the trend is an artifact of forcing an exponential fit onto convectively flushed profiles.

    Authors: We agree that an explicit derivation of the apparent first-order form and quantitative fit diagnostics are needed to support the analysis. The time-dependent k(t) is introduced as a phenomenological descriptor to characterize how release kinetics evolve with flow conditions, rather than as an exact solution to the advection-diffusion equations. In the revised manuscript, we will add a derivation of k(t) from the integrated mass balance, report R² values and residual plots for representative low- and high-Re cases, and briefly discuss the applicability of the first-order form under advection-dominated regimes. These additions will confirm that the late-stage increase in k(t) at high Re arises from enhanced convective flushing and is not a fitting artifact. revision: yes

  2. Referee: [§3] §3 (numerical methods): No mesh convergence studies, solver tolerances, or specific ranges/values for permeability, porosity, and the Forchheimer coefficient are reported. These choices are load-bearing for the reliability of the simulated release curves and the extracted k(t) trends.

    Authors: We acknowledge that these numerical details are essential for reproducibility and reliability. The revised manuscript will include mesh convergence studies, the solver tolerances used, and the specific values (or ranges) for permeability, porosity, and the Forchheimer coefficient. revision: yes

  3. Referee: [Abstract and §5] Abstract and §5 (conclusions): The statement that the conditions 'ensure a prolonged operational time period' is not quantified (e.g., via time-to-50%-release or comparison metrics across Re), weakening the link between the k(t) observation and the design implication.

    Authors: We will revise the abstract and section 5 to quantify the prolonged operational time using metrics such as time-to-50%-release and direct comparisons across Reynolds numbers, thereby strengthening the connection to the design implications. revision: yes

Circularity Check

0 steps flagged

No circularity: numerical simulation followed by descriptive post-processing analysis

full rationale

The paper solves the Forchheimer-extended Darcy and advection-diffusion equations numerically to compute the drug mass release M(t) under varying flow and porous media conditions. It then post-processes this output by re-expressing the release rate in the form of an apparent first-order process with a derived time-dependent rate constant k(t) = -(1/M) dM/dt. This is a definitional reparametrization of the computed M(t) curve rather than an input assumption that forces the reported behaviors (such as the late-stage increase in k(t) at high Re). No load-bearing claim reduces to a self-citation, fitted parameter, or ansatz by construction; the physical results originate from the independent PDE solution and are merely analyzed in the chosen coordinates. The chain is self-contained.

Axiom & Free-Parameter Ledger

0 free parameters · 2 axioms · 0 invented entities

Abstract-only; the model rests on standard continuum assumptions for porous media and dilute transport. No explicit free parameters or invented entities are named, but the time-dependent rate constant is introduced as a descriptive device.

axioms (2)
  • domain assumption Flow through the porous implant obeys the Forchheimer-extended Darcy law
    Stated in abstract as the modeling choice for saturated porous medium
  • domain assumption Drug transport follows diluted species transport equations
    Standard continuum transport model invoked for diffusion and convection

pith-pipeline@v0.9.0 · 5534 in / 1294 out tokens · 47156 ms · 2026-05-08T07:15:53.885582+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Reference graph

Works this paper leans on

37 extracted references

  1. [1]

    In contrast, this lower limit diminishes and approaches zero for higher-permeability cases

    For cases with lower permeability, a minimum drug depletion time from the implant is observed, regardless of variations in porosity and Reynolds number. In contrast, this lower limit diminishes and approaches zero for higher-permeability cases

  2. [2]

    on - and-off

    By fine -tuning Reynolds numbers, permeability, and effective diffusivity, the drug depletion rate can be slowed down, while also enabling a significant increase in the rate constant following an initial decline. This opens up exciting opportunities to design DFPI systems with controlled "on - and-off" release patterns, tailored to meet specific therapeutic goals

  3. [3]

    It also appears to be correlated with the evolution of rate constants

    Ratio of internal diffusive and convective fluxes in DFPI decide the depletion dynamics and drug distribution with time. It also appears to be correlated with the evolution of rate constants. This study specifically focuses on the convection - diffusion-driven drug release from porous implants (DFPIs). However, other factors like erosion, swelling, pH cha...

    2021

  4. [4]

    S. J. Buwalda, T. Vermonden, and W. E. Hennink, Hydrogels for Therapeutic Delivery: Current Developments and Future Directions, Biomacromolecules 18, 316 (2017)

    2017

  5. [5]

    Naahidi, M

    S. Naahidi, M. Jafari, M. Logan, Y. Wang, Y. Yuan, H. Bae, B. Dixon, and P. Chen, Biocompatibility of hydrogel -based scaffolds for tissue engineering applications, Biotechnol Adv 35, 530 (2017)

    2017

  6. [6]

    Foudazi, R

    R. Foudazi, R. Zowada, I. Manas -Zloczower, and D. L. Feke, Porous Hydrogels: Present Challenges and Future Opportunities, Langmuir 39, 2092 (2023)

    2092

  7. [7]

    Patel and P

    P. Patel and P. Thareja, Hydrogels differentiated by length scales: A review of biopolymer-based hydrogel preparation methods, characterization techniques, and targeted applications, Eur Polym J 163, 110935 (2022)

    2022

  8. [8]

    Z. Li, Y. Zhou, T. Li, J. Zhang, and H. Tian, Stimuli-responsive hydrogels: Fabrication and biomedical applications, View 3, 20200112 (2022)

    2022

  9. [9]

    Salehi, S

    S. Salehi, S. M. Naghib, H. R. Garshasbi , S. Ghorbanzadeh, and W. Zhang, Smart stimuli - responsive injectable gels and hydrogels for drug delivery and tissue engineering applications: A review, Front Bioeng Biotechnol 11, 1104126 (2023)

    2023

  10. [10]

    Brighenti and M

    R. Brighenti and M. P. Cosma, Mechanics of multi-stimuli temperature -responsive hydrogels, J Mech Phys Solids 169, 105045 (2022)

    2022

  11. [11]

    Irfan, M

    J. Irfan, M. A. Hussain, M. T. Haseeb, A. Ali, M. Farid-Ul-Haq, T. Tabassum, S. Z. Hussain, I. Hussain, and M. Naeem -Ul-Hassan, A pH - sensitive, stimuli-responsive, superabsorbent, smart hydrogel from psyllium ( Plantago ovata ) for intelligent drug delive ry, RSC Adv 11, 19755 (2021)

    2021

  12. [12]

    R. D. Manga and P. K. Jha, Mathematical Models for Controlled Drug Release Through pH-Responsive Polymeric Hydrogels, J Pharm Sci 106, 629 (2017)

    2017

  13. [13]

    Y. Xing, B. Zeng, and W. Yang, Light responsive hydrogels for controlled drug delivery, Front Bioeng Biotechnol 10, 1075670 (2022)

    2022

  14. [14]

    Vázquez-González and I

    M. Vázquez-González and I. Willner, Stimuli- Responsive Biomolecule -Based Hydrogels and Their Applications, Angewandte Chemie International Edition 59, 15342 (2020)

    2020

  15. [15]

    Y. Wang, J. Li, M. Tang, C. Peng, G. Wang, J. Wang, X. Wang, X. Chang, J. Guo, and S. Gui, Smart stimuli -responsive hydrogels for drug delivery in periodontitis treatment, Biomedicine & Pharmacotherapy 162, 114688 (2023)

    2023

  16. [16]

    N. Gull, S. M. Khan, M. T. Zahid Butt, S. Khalid, M. Shafiq, A. Islam, S. Asim, S. Hafeez, and R. U. Khan, In vitro study of chitosan-based multi-responsive hydrogels as drug release vehicles: a preclinical study, RSC Adv 9, 31078 (2019)

    2019

  17. [17]

    T. R. Hoare and D. S. Kohane, Hydrogels in drug delivery: Progress and challenges, Polymer (Guildf) 49, 1993 (2008)

    1993

  18. [18]

    Khanafer and K

    K. Khanafer and K. Vafai, The role of porous media in biomedical engineering as related to magnetic resonance imaging and drug delivery, Heat and Mass Transfer/Waerme - Und Stoffuebertragung 42, 939 (2006)

    2006

  19. [19]

    Duong, C

    T. Duong, C. López-Iglesias, P. K. Szewczyk, U. Stachewicz, J. Barros, C. Alvarez-Lorenzo, M. Alnaief, and C. A. García -González, A Pathway From Porous Particle Technology Toward Tailoring Aerogels for Pulmonary Drug Administration, Front Bioeng Biotechnol 9, 671381 (2021)

    2021

  20. [20]

    Verma, A

    N. Verma, A. Singh, V. Yadav, P. Singh, A. Yadav, and S. Jaiswal, Super Porous Hydrogel Based Drug Delivery System: A Review, South Asian Research Journal of Pharmaceutical Sciences 3, 103 (2021)

    2021

  21. [21]

    P. K. Pandey, M. Jain, and P. K. Jha, Drug delivery from a ring implant attached to intraocular lens: An in -silico investigation, J Pharm Sci 113, 3332 (2024)

    2024

  22. [22]

    J ． Penn and M

    M. J ． Penn and M. G. Hennessy, Optimal loading of hydrogel -based drug -delivery systems, Appl Math Model 112, 649 (2022)

    2022

  23. [23]

    C. C. Lin and A. T. Metters, Hydrogels in controlled release formulations: Network design and mathematical modeling, Adv Drug Deliv Rev 58, 1379 (2006). 13

    2006

  24. [24]

    P. K. Pandey, R. Agrawal, P. Mukul, and M. K. Das, Study on Pulsatile Blood Flow in Cerebral Stenosed Artery, in Fluid Mechanics and Fluid Power , edited by T. Prabu, P. Viswanathan, A. Agrawal, and J. Banerjee (Springer Singapore, Singapore, 2021), pp. 581–588

    2021

  25. [25]

    Skalak, S

    R. Skalak, S. R. Keller, and T. W. Secomb, Mechanics of blood flow., J Biomech Eng 103, 102 (1981)

    1981

  26. [26]

    A. F. R. Pimenta, A. P. Serro, R. Colaço, and A. Chauhan, Optimization of intraocular lens hydrogels for dual drug release: Experimentation and modelling, European Journal of Pharmaceutics and Biopharmaceutics 141, 51 (2019)

    2019

  27. [27]

    A. F. R. Pimenta, A. P. Serro, R. Colaço, and A. Chauhan, Drug delivery to the eye anterior chamber by intraocular lenses: An in vivo concentration estimation model, European Journal of Pharmaceutics and Biopharmaceutics 133, 63 (2018)

    2018

  28. [28]

    D. King, C. McCormick, and S. McGinty, How Does Fluid Flow Influence Drug Release from Drug Filled Implants?, Pharm Res 39, 25 (2022)

    2022

  29. [29]

    Tjaden, S

    B. Tjaden, S. J. Cooper, D. J. Brett, D. Kramer, and P. R. Shearing, On the Origin and Application of the Bruggeman Correlation for Analysing Transport Phenomena in Electrochemical Systems, Current Opinion in Chemical Engineering

  30. [30]

    C. Seol, T. Kim, and T. Kim, The effect of permeability on the flow structure of porous square cylinders, J Fluid Mech 985, A29 (2024)

    2024

  31. [31]

    Hou and P

    R. Hou and P. Li, Flow control and heat transfer enhancement inside a two - dimensional channel using porous blocks and applying bleeding condition between them, J Therm Anal Calorim 143, 2609 (2021)

    2021

  32. [32]

    Śnieżek, S

    D. Śnieżek, S. B. Naqvi, and M. Matyka, Inertia onset in disordered porous media flow, Phys Rev E 110, (2024)

    2024

  33. [33]

    M. S. Gomes-Filho, M. A. A. Barbosa, and F. A. Oliveira, A statistical mechanical model for drug release: Relations between release parameters and porosity, Physica A: Statistical Mechanics and Its Applications 540, 123165 (2020)

    2020

  34. [34]

    Zhang and R

    Q. Zhang and R. Fassihi, Release rate determination from in situ gel forming PLGA implant: a novel ‘shape -controlled basket in tube’ method, Journal of Pharmacy and Pharmacology 72, 1038 (2020)

    2020

  35. [35]

    Sinn Aw, M

    M. Sinn Aw, M. Kurian, and D. Losic, Non - eroding drug-releasing implants with ordered nanoporous and nanotubular structures: concepts for controlling drug release, Biomater Sci 2, 10 (2013)

    2013

  36. [36]

    Farzan, R

    M. Farzan, R. Roth, J. Schoelkopf, J. Huwyler, and M. Puchkov, The processes behind drug loading and release in porous drug delivery systems, European Journal of Pharmaceutics and Biopharmaceutics 189, 133 (2023)

    2023

  37. [37]

    Donbrow and Y

    M. Donbrow and Y. Samuelov, Zero order drug delivery from double -layered porous films: release rate profiles from ethyl cellulose, hydroxypropyl cellulose and polyethylene glycol mixtures, Journal of Pharmacy and Pharmacology 32, 463 (1980)

    1980